Veru (STU:FMW) Other Net Income (Loss) : €-6.86 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Veru Other Net Income (Loss)?

Veru's Other Net Income (Loss) for the three months ended in Mar. 2025 was €-0.05 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was €-6.86 Mil.

Veru's quarterly Other Net Income (Loss) declined from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€-6.81 Mil) but then increased from Dec. 2024 (€-6.81 Mil) to Mar. 2025 (€-0.05 Mil).

Veru's annual Other Net Income (Loss) increased from Sep. 2022 (€-0.00 Mil) to Sep. 2023 (€0.00 Mil) but then declined from Sep. 2023 (€0.00 Mil) to Sep. 2024 (€-0.00 Mil).

Veru Other Net Income (Loss) Historical Data

The historical data trend for Veru's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Other Net Income (Loss) Chart

Veru Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Other Net Income (Loss)

Get a 7-Day Free Trial

Veru Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-1.05	-	-	-6.81	-0.05

Veru Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.86 Mil.

Veru Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Veru's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

VERU:USA

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Veru Headlines

No Headlines